Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B
Article in Antiviral Research (July 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Antiviral Research (July 2024)
Article in Cellular & Molecular Immunology (May 2024)
Article in Antiviral Research (May 2024)